Literature DB >> 22311900

Sympathetic signatures of cardiovascular disease: a blueprint for development of targeted sympathetic ablation therapies.

John W Osborn, Marcos T Kuroki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22311900      PMCID： PMC3635843          DOI： 10.1161/HYPERTENSIONAHA.111.182899

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

Review 1.  Differential control of sympathetic outflow.

Authors:  S F Morrison
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-09       Impact factor: 3.619

2.  Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.

Authors:  Felix Mahfoud; Markus Schlaich; Ingrid Kindermann; Christian Ukena; Bodo Cremers; Mathias C Brandt; Uta C Hoppe; Oliver Vonend; Lars C Rump; Paul A Sobotka; Henry Krum; Murray Esler; Michael Böhm
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

3.  Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure.

Authors:  Rohit Ramchandra; Sally G Hood; Anna M D Watson; Andrew M Allen; Clive N May
Journal:  Hypertension       Date:  2012-02-06       Impact factor: 10.190

4.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

5.  Renal sympathetic-nerve ablation for uncontrolled hypertension.

Authors:  Markus P Schlaich; Paul A Sobotka; Henry Krum; Elisabeth Lambert; Murray D Esler
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

6.  Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy.

Authors:  Aram V Chobanian
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

7.  Differential drives from rostral ventrolateral medullary neurons to three identified sympathetic outflows.

Authors:  R M McAllen; C N May
Journal:  Am J Physiol       Date:  1994-10

Review 8.  Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation.

Authors:  John W Osborn; Gregory D Fink; Marcos T Kuroki
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

9.  The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.

Authors:  Murray Esler
Journal:  J Appl Physiol (1985)       Date:  2009-11-25

10.  Effect of stellate ganglionectomy on basal cardiovascular function and responses to beta1-adrenoceptor blockade in the rat.

Authors:  Misa Yoshimoto; Erica A Wehrwein; Martin Novotny; Greg M Swain; David L Kreulen; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-17       Impact factor: 4.733
  10 in total
  13 in total

Review 1.  Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases.

Authors:  Priya Balasubramanian; Delton Hall; Madhan Subramanian
Journal:  Geroscience       Date:  2018-12-05       Impact factor: 7.713

2.  Dynamic interaction between the heart and its sympathetic innervation following T5 spinal cord transection.

Authors:  Heidi L Lujan; Hussein Janbaih; Stephen E DiCarlo
Journal:  J Appl Physiol (1985)       Date:  2012-06-21

3.  Total sleep deprivation alters cardiovascular reactivity to acute stressors in humans.

Authors:  Huan Yang; John J Durocher; Robert A Larson; Joseph P Dellavalla; Jason R Carter
Journal:  J Appl Physiol (1985)       Date:  2012-07-19

4.  Development of manganese-enhanced magnetic resonance imaging of the rostral ventrolateral medulla of conscious rats: Importance of normalization and comparison with other regions of interest.

Authors:  Daniel J Huereca; Konstandinos A Bakoulas; Farhad Ghoddoussi; Bruce A Berkowitz; Avril Genene Holt; Patrick J Mueller
Journal:  NMR Biomed       Date:  2018-01-12       Impact factor: 4.044

5.  Preventive effect of gomisin J from Schisandra chinensis on angiotensin II-induced hypertension via an increased nitric oxide bioavailability.

Authors:  Byeong Hyeok Ye; Seung Jin Lee; Young Whan Choi; So Youn Park; Chi Dae Kim
Journal:  Hypertens Res       Date:  2014-11-27       Impact factor: 3.872

6.  Liver sympathetic denervation reverses obesity-induced hepatic steatosis.

Authors:  Chansol Hurr; Hayk Simonyan; Donald A Morgan; Kamal Rahmouni; Colin N Young
Journal:  J Physiol       Date:  2019-07-26       Impact factor: 5.182

Review 7.  Neural Control of Non-vasomotor Organs in Hypertension.

Authors:  Chansol Hurr; Colin N Young
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

8.  Effect of global and regional sympathetic blockade on arterial pressure during water deprivation in conscious rats.

Authors:  Britta J Veitenheimer; William C Engeland; Pilar A Guzman; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

Review 9.  The Interactions of the Immune System and the Brain in Hypertension.

Authors:  Marialuisa Perrotta; Giuseppe Lembo; Daniela Carnevale
Journal:  Curr Hypertens Rep       Date:  2018-02-24       Impact factor: 5.369

Review 10.  (In)activity-related neuroplasticity in brainstem control of sympathetic outflow: unraveling underlying molecular, cellular, and anatomical mechanisms.

Authors:  Nicholas A Mischel; Madhan Subramanian; Maryetta D Dombrowski; Ida J Llewellyn-Smith; Patrick J Mueller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-08       Impact factor: 4.733
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.